AbbVie Inc

Common Name
AbbVie
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
55,000
Ticker
ABBV
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
AbbVie Inc. is a prominent biopharmaceutical company that focuses on developing innovative therapies addressing some of the world's most challenging diseases. Originating from a 2013 spinoff of Abbott...

AbbVie's GHG Emissions Data Preview

In 2024, AbbVie completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, AbbVie has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind AbbVie’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore AbbVie’s data sources below and access millions more through our Disclosure Search.

a. AbbVie's ESG Data Spreadsheet 2024
a. AbbVie's ESG Data Spreadsheet 2024
b. AbbVie's Environmental Report 2020
b. AbbVie's Environmental Report 2020

Insights into AbbVie's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of AbbVie amounted to 541,214 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of AbbVie decreased by 4.37%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

AbbVie's Scope 1 Emissions Over Time

2018201920202021202220232024095 k190 k285 k380 ktCO2e0%-16%+39%-7%-4%-9%
  • Total Scope 1
  • Year-over-Year Change

What are AbbVie's Scope 1 emissions?

In 2024, the total Scope 1 emissions of AbbVie were 300,072 metric tons of CO₂ equivalent (tCO₂e). a

Has AbbVie reduced its Scope 1 emissions over time?

Since 2018, AbbVie's Scope 1 emissions have decreased by 4.44%, reflecting a declining long-term trend in Scope 1 emissions over time. a b

Compared to the previous year (2023), AbbVie's Scope 1 emissions decreased by 8.59%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a

What are AbbVie's Scope 2 emissions?

In 2024, AbbVie reported Scope 2 greenhouse gas (GHG) emissions of 122,287 tCO₂e using the market-based method and 241,142 tCO₂e using the location-based method. a

Has AbbVie reduced its Scope 2 emissions over time?

Compared to the previous year (2023), AbbVie's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that AbbVie 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does AbbVie use for Scope 2 reporting?

In 2024, AbbVie reported its Scope 2 emissions using the market-based method and using the location-based method. a

AbbVie's Scope 2 Emissions Over Time

2018201920202021202220232024085 k170 k255 k340 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into AbbVie’s GHG Emissions Intensity Compared to Industry Peers

In 2024, AbbVie reported Scope 1 greenhouse gas (GHG) emissions of 300,072 tCO₂e and total revenues of USD 56,334 millions. This translates into an emissions intensity of 5.33 tCO₂e per millions USD. a

AbbVie's Scope 1 Emissions Intensity Compared to Peers

5005,00050,000200,0002,000,000Scope 1 Emissions (tCO2e)2001,00010,000100,000500,000Revenues (Millions of USD)IMolina HealthcareYear: 2024Scope 1: 6,890 tCO2eRevenue: $M 40,646Scope 1 Intensity: 0.17 tCO2e/$MAbbott LaboratoriesYear: 2024Scope 1: 502,000 tCO2eRevenue: $M 41,950Scope 1 Intensity: 11.97 tCO2e/$MEli Lilly and CoYear: 2024Scope 1: 192,000 tCO2eRevenue: $M 45,043Scope 1 Intensity: 4.26 tCO2e/$MBristol-Myers SquibbYear: 2024Scope 1: 206,726 tCO2eRevenue: $M 48,300Scope 1 Intensity: 4.28 tCO2e/$MJohnson & JohnsonYear: 2024Scope 1: 314,690 tCO2eRevenue: $M 88,820Scope 1 Intensity: 3.54 tCO2e/$MDanaherYear: 2024Scope 1: 109,046 tCO2eRevenue: $M 23,875Scope 1 Intensity: 4.57 tCO2e/$MBecton Dickinson and CoYear: 2023Scope 1: 162,475 tCO2eRevenue: $M 19,372Scope 1 Intensity: 8.39 tCO2e/$MGilead SciencesYear: 2024Scope 1: 53,856 tCO2eRevenue: $M 28,754Scope 1 Intensity: 1.87 tCO2e/$MBiogenYear: 2024Scope 1: 56,611 tCO2eRevenue: $M 9,676Scope 1 Intensity: 5.85 tCO2e/$MPfizerYear: 2024Scope 1: 613,218 tCO2eRevenue: $M 63,627Scope 1 Intensity: 9.64 tCO2e/$MAmgenYear: 2024Scope 1: 147,000 tCO2eRevenue: $M 33,424Scope 1 Intensity: 4.40 tCO2e/$MOrganon & CoYear: 2024Scope 1: 34,200 tCO2eRevenue: $M 6,403Scope 1 Intensity: 5.34 tCO2e/$MMerck & Co IncYear: 2024Scope 1: 721,200 tCO2eRevenue: $M 64,168Scope 1 Intensity: 11.24 tCO2e/$MIIIntegra Lifesciences HoldingsYear: 2024Scope 1: 14,555 tCO2eRevenue: $M 1,611Scope 1 Intensity: 9.04 tCO2e/$MDexcomYear: 2023Scope 1: 5,383 tCO2eRevenue: $M 3,622Scope 1 Intensity: 1.49 tCO2e/$MBoston ScientificYear: 2024Scope 1: 87,567 tCO2eRevenue: $M 16,747Scope 1 Intensity: 5.23 tCO2e/$MQuidelOrthoYear: 2023Scope 1: 22,544 tCO2eRevenue: $M 2,998Scope 1 Intensity: 7.52 tCO2e/$MElevance HealthYear: 2024Scope 1: 14,390 tCO2eRevenue: $M 176,781Scope 1 Intensity: 0.08 tCO2e/$MEnvista HoldingsYear: 2024Scope 1: 3,000 tCO2eRevenue: $M 2,511Scope 1 Intensity: 1.19 tCO2e/$MBioMarin PharmaceuticalYear: 2022Scope 1: 14,000 tCO2eRevenue: $M 2,096Scope 1 Intensity: 6.68 tCO2e/$MIntuitive SurgicalYear: 2024Scope 1: 8,105 tCO2eRevenue: $M 8,352Scope 1 Intensity: 0.97 tCO2e/$MIonis PharmaceuticalsYear: 2024Scope 1: 2,616 tCO2eRevenue: $M 705Scope 1 Intensity: 3.71 tCO2e/$MAbbVieYear: 2024Scope 1: 300,072 tCO2eRevenue: $M 56,334Scope 1 Intensity: 5.33 tCO2e/$M

How does AbbVie's GHG emissions intensity compare to its peers?

In 2024, AbbVie reported a Scope 1 emissions intensity of 5.33 tCO₂e per millions USD. Compared to the peer group median of 4.48 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a

Where does AbbVie rank on GHG emissions intensity within its industry?

In 2024, AbbVie ranked 14 out of 22 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

AbbVie is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to AbbVie's GHG Emissions Dataset?
Sign Up